Skip to main content

Table 1 Clinical characterization of the patients

From: Phenotypic and functional evaluations of peripheral blood monocytes from chronic-form paracoccidioidomycosis patients before and after treatment

Patients Sex Age* Degree of severity* DID (1: ) - Admission* Group Antifungal Length of treatment (months)** Length after treatment (months)**
P1 M 60 Moderate 16 NTG - - -
P2 M 53 Severe 128 NTG - - -
P3 M 59 Moderate 32 NTG - - -
P4 F 47 Moderate 64 NTG - - -
P5 M 44 Moderate 64 NTG - - -
P6 M 51 Mild NR NTG - - -
P7 M 64 Moderate 32 NTG - - -
P8 M 59 Moderate 32 NTG - - -
P9 M 52 Moderate 8 NTG - - -
P10 M 47 Moderate 32 NTG - - -
P11 M 37 Moderate 4 NTG - - -
P12 M 56 Moderate 16 ACG CMX 25 28
P13 M 39 Severe 64 ACG CMX 173 37
P14 M 60 Mild 16 ACG CMX 97 45
P15 M 56 Moderate 16 ACG CMX 26 3
P16 M 50 Moderate 512 ACG CMX 53 62
P17 M 42 Moderate 8 ACG CMX 28 83
P18 M 42 Moderate NR ACG ITC 31 69
P19 M 39 Moderate 2 ACG ITC 32 27
P20 M 40 Severe 128 ACG CMX/ITC 33(CMX)/49(ITC) 89
P21 M 42 Severe 64 ACG CMX/ITC 6(CMX)/131(ITC) 53
P22 M 51 Severe 128 ACG CMX/ITC 44(CMX)/12(ITC) 60
P23 M 53 Severe 64 ACG CMX 84 65
  1. DID = double agar gel immunodiffusion test; NR = non-reagent; NTG = non-treated group; ACG = apparent cure group; CMX = cotrimoxazole; ITC = Itraconazole.
  2. *Homogeneity (NTG x ACG):
  3. Age: NTG =52 (37–64); ACG = 46 (39-60); p =0.18 (Mann–Whitney U test).
  4. Degree of severity: NTG = ACG; p =0.31 (Fisher's exact test).
  5. DID admission: NTG =32 (NR-1:128); ACG =32 (NR-1:512); p =0.66 (Mann-Whitney U test).
  6. **Length of treatment (Mean ± SEM): 68 ± 14; Length after treatment (Mean ± SEM): 52 ± 7.